HydroWhirl S tank cleaning nozzle now ATEX certified
For use in atmospheres that are potentially explosive
The HydroWhirl is designed to meet the exacting standards for effective cleaning-in-place (CIP) required in the pharmaceutical, chemical, food, dairy and beverage industries. As well as being certified for use in potentially explosive areas, the ATEX certified nozzles also meet the requirements for gas and dust approvals for all zones (0,1 and 2).
HydroWhirl nozzles are self-cleaning and self-lubricating, which eliminates the possibility of process contamination, while its compact design allows it to be fitted through small, restricted access flanges. They are ideal for medium tanks (up to 5 metres in diameter), used in the pharmaceutical and chemical, food and petrochemical industries, where superior cleaning combined with reduced cycle times, lower water, energy and chemical consumption are increasingly becoming important considerations.
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing]()
How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing
Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance processes and maintain reliable output across demanding production lines
Ingredients
![UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny]()
UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny
The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical manufacturers face growing pressure around the use of forever chemicals
Manufacturing
![Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India]()
Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India
The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at its Raichur campus, expanding its capabilities to meet demand for GLP-1s and increasingly complex peptide therapeutics across oncology and rare diseases
Pharmaceutical
![OGT launches four IVDR-certified CytoCell FISH probes for haematological malignancy diagnostics]()
OGT launches four IVDR-certified CytoCell FISH probes for haematological malignancy diagnostics
The new probes advance OGT’s transition of its CytoCell portfolio from IVDD ahead of the December 2028 Class C deadline, helping laboratories maintain compliant leukaemia and myeloma testing workflows
